Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberta Magliozzi

Showing results (21-30 of 89) with videos related to

Pageof 9
Sort By:
Frontiers in Cellular Neuroscience|July 23, 2020
Aging, Cellular Senescence, and Progressive Multiple SclerosisDimitrios Papadopoulos, Roberta Magliozzi, Dimos D Mitsikostas, et al.
Nature Reviews. Neuroscience|February 21, 2015
Exploring the origins of grey matter damage in multiple sclerosisMassimiliano Calabrese, Roberta Magliozzi, Olga Ciccarelli, et al.
Journal of Neuropathology and Experimental Neurology|December 18, 2012
B-cell enrichment and Epstein-Barr virus infection in inflammatory cortical lesions in secondary progressive multiple sclerosisRoberta Magliozzi, Barbara Serafini, Barbara Rosicarelli, et al.
Brain : a Journal of Neurology|November 2, 2013
Cortical grey matter demyelination can be induced by elevated pro-inflammatory cytokines in the subarachnoid space of MOG-immunized ratsChristopher Gardner, Roberta Magliozzi, Pascal F Durrenberger, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 28, 2017
Dimethyl fumarate: a possible exit strategy from natalizumab treatment in patients with multiple sclerosis at risk for severe adverse eventsMassimiliano Calabrese, Marco Pitteri, Gabriele Farina, et al.
Journal of Neuropathology and Experimental Neurology|February 8, 2006
Dendritic cells in multiple sclerosis lesions: maturation stage, myelin uptake, and interaction with proliferating T cellsBarbara Serafini, Barbara Rosicarelli, Roberta Magliozzi, et al.
Journal of Neuroimmunology|July 28, 2006
Suppression of established experimental autoimmune encephalomyelitis and formation of meningeal lymphoid follicles by lymphotoxin beta receptor-Ig fusion proteinSandra Columba-Cabezas, Marilena Griguoli, Barbara Rosicarelli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 11, 2021
Volume changes of thalamus, hippocampus and cerebellum are associated with specific CSF profile in MSAlbulena Bajrami, Roberta Magliozzi, Anna I Pisani, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 25, 2025
Acute TREM2 inhibition depletes MAFB-high microglia and hinders remyelinationJinchao Hou, Roberta Magliozzi, Yun Chen, et al.
Annals of Neurology|December 27, 2023
High Levels of Perivascular Inflammation and Active Demyelinating Lesions at Time of Death Associated with Rapidly Progressive Multiple Sclerosis Disease Course: A Retrospective Postmortem Cohort StudyRichard Nicholas, Roberta Magliozzi, Damiano Marastoni, et al.
Pageof 9

Showing results (21-30 of 89) with videos related to

Sort By:
Pageof 9
Frontiers in Cellular Neuroscience|July 23, 2020
Aging, Cellular Senescence, and Progressive Multiple SclerosisDimitrios Papadopoulos, Roberta Magliozzi, Dimos D Mitsikostas, et al.
Nature Reviews. Neuroscience|February 21, 2015
Exploring the origins of grey matter damage in multiple sclerosisMassimiliano Calabrese, Roberta Magliozzi, Olga Ciccarelli, et al.
Journal of Neuropathology and Experimental Neurology|December 18, 2012
B-cell enrichment and Epstein-Barr virus infection in inflammatory cortical lesions in secondary progressive multiple sclerosisRoberta Magliozzi, Barbara Serafini, Barbara Rosicarelli, et al.
Brain : a Journal of Neurology|November 2, 2013
Cortical grey matter demyelination can be induced by elevated pro-inflammatory cytokines in the subarachnoid space of MOG-immunized ratsChristopher Gardner, Roberta Magliozzi, Pascal F Durrenberger, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 28, 2017
Dimethyl fumarate: a possible exit strategy from natalizumab treatment in patients with multiple sclerosis at risk for severe adverse eventsMassimiliano Calabrese, Marco Pitteri, Gabriele Farina, et al.
Journal of Neuropathology and Experimental Neurology|February 8, 2006
Dendritic cells in multiple sclerosis lesions: maturation stage, myelin uptake, and interaction with proliferating T cellsBarbara Serafini, Barbara Rosicarelli, Roberta Magliozzi, et al.
Journal of Neuroimmunology|July 28, 2006
Suppression of established experimental autoimmune encephalomyelitis and formation of meningeal lymphoid follicles by lymphotoxin beta receptor-Ig fusion proteinSandra Columba-Cabezas, Marilena Griguoli, Barbara Rosicarelli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 11, 2021
Volume changes of thalamus, hippocampus and cerebellum are associated with specific CSF profile in MSAlbulena Bajrami, Roberta Magliozzi, Anna I Pisani, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 25, 2025
Acute TREM2 inhibition depletes MAFB-high microglia and hinders remyelinationJinchao Hou, Roberta Magliozzi, Yun Chen, et al.
Annals of Neurology|December 27, 2023
High Levels of Perivascular Inflammation and Active Demyelinating Lesions at Time of Death Associated with Rapidly Progressive Multiple Sclerosis Disease Course: A Retrospective Postmortem Cohort StudyRichard Nicholas, Roberta Magliozzi, Damiano Marastoni, et al.
Pageof 9